[摘要] 目的 探讨卡维地洛治疗糖尿病高血压患者心律失常的疗效和安全性。方法 选取该科2017年10月—2018年10月收治的糖尿病高血压合并心律失常患者66例，随机分为两组，各33例，对照组给予美托洛尔，观察组在对照组的基础上给予卡维地洛。结果 观察组FPG、SBP、DBP、HR各指标较对照组显著降低(P<0.05);观察组不良反应发生率为9.1%，与对照组比较差异无统计学意义(P>0.05)。结论 糖尿病高血压合并心律失常患者采用卡维地洛治疗，可有效改善心率，安全性高。

    [关键词] 卡维地洛;糖尿病;高血压;心律失常

    [中图分类号] R587.1 [文献标识码] A [文章编号] 1672-4062(2019)06(b)-0101-02

    [Abstract] Objective To investigate the efficacy and safety of carvedilol in the treatment of arrhythmia in patients with diabetes mellitus. Methods 66 patients with diabetes mellitus complicated with arrhythmia admitted to our department from October 2017 to October 2018 were randomly divided into two groups ......